There is 1 paper on MIR-465 in aging research: none in people yet, 1 in animals.
1 paper studies it3 findings
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: National Institute of General Medical Sciences and 2 more
- Animals1
Effects
3IGF-1 protein
downin mice1
1 study
IGF-1 protein
downin mice1
MIR-465 decreases IGF-1 protein in mice (shown by in vivo upregulation).
“There is a corresponding reduction in IGF-1 protein levels in the liver and plasma.”
Animalsshown by in vivo upregulationliver and plasma
Frontiers in aging
Growth hormone axis
downin mice1
1 study
Growth hormone axis
downin mice1
MIR-465 decreases growth hormone axis in mice (shown by in vivo upregulation).
“Upregulation of mir-465 in vivo leads to a reduction in GHR mRNA in the liver and an attenuation of GH signaling”
Animalsshown by in vivo upregulationliver
Frontiers in aging
GHR
downin mice1
1 study
GHR
downin mice1
MIR-465 decreases GHR in mice (shown by in vivo upregulation).
“Upregulation of mir-465 in vivo leads to a reduction in GHR mRNA in the liver”
Animalsshown by in vivo upregulationliver
Frontiers in aging
Latest
Frontiers in Aging
A cluster of X-linked miRNAs are de-repressed with age in mouse liver and target growth hormone signaling
Experiments in miceGrowth hormone axis